FDA Inspection 1035090 — Garonit Pharmaceutical, Inc.
The FDA completed an inspection of Garonit Pharmaceutical, Inc. on November 28, 2017 in Fairfield, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 28, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Fairfield, NJ (United States)